V. Watkins

发表

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.

F. Montorsi, S. Segal, J. Denne, 2004, European urology.

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.

T. Costigan, C. McMahon, G. Brock, 2002, The Journal of urology.

Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones.

W. Hellstrom, J. Overstreet, C. Beasley, 2003, The Journal of urology.

Long-term safety experience with tadalafil

F. Montorsi, J. Denne, L. Valiquette, 2003 .

Tonsillar Tissue Penetration of Dirithromycin after Multiple Doses

G. Sides, P. Conforti, S. Manning, 1996, Journal of clinical pharmacology.

Drug Interactions of Macrolides: Emphasis on Dirithromycin

R. Polk, J. Stotka, V. Watkins, 1997, The Annals of pharmacotherapy.

Comparison of dirithromycin and penicillin for treatment of streptococcal pharyngitis

G. Sides, P. Conforti, M. Smietana, 1997, Antimicrobial agents and chemotherapy.

Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study.

R. Rosen, K. Saikali, W. Pullman, 2004, The journal of sexual medicine.

Enzastaurin safety review: Data from phase I and phase II trials.

B. Lin, V. Watkins, S. Hong, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

P-302: Blood pressure and cardiovascular effects of tadalafil, a new PDE5 inhibitor

T. Costigan, M. Mitchell, A. Bedding, 2002 .

P-313: Efficacy and safety of tadalafil in men with erectile dysfunction with and without hypertension

T. Costigan, C. McMahon, G. Brock, 2002 .